Real patient stories
Meaningful stories. Meaningful hope.
Hear the experiences of people living with advanced CSCC, a type of skin cancer that has spread or cannot be cured by surgery or radiation. Learn about their personal journeys with advanced CSCC and their experiences with LIBTAYO.
LIBTAYO is a prescription medicine used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC). LIBTAYO may be used to treat CSCC that has spread or cannot be cured by surgery or radiation.
Individual results may vary.
Chris’ Story
Play the video below to see her story.
Actual LIBTAYO patient. Individual results may vary.
"My perspective on life has changed dramatically. Time is short, so it’s very important to spend it with your friends and family, and appreciate the daily things."
Chris shares her story about living with metastatic CSCC (CSCC that has spread). Listen as she takes you through her journey, from initially being misdiagnosed to the chaIlenges she faces managing life with metastatic CSCC, and her treatment experience with LIBTAYO.
Bill and Cathie's Story
Play the video below to see their story.
Actual LIBTAYO patient. Individual results may vary.
"I've gone through some ups and downs in life, and this was part of my journey. The best things you can do to honor yourself is staying positive..." – Bill
After Bill was diagnosed with stage 4 CSCC, he and his wife Cathie turned to each other for support. And when surgery and radiation were no longer possible, they turned to LIBTAYO to manage Bill’s condition. Hear how they worked with Bill's doctor and chose treatment with LIBTAYO.
Meet Dave
Actual LIBTAYO patient. Individual results may vary.
"Having a good support system in place is important. My wife has really helped me a lot through all of my struggles...and my brother has been very supportive in my journey."
Dave underwent many forms of treatment for advanced CSCC. Read Dave's blog posts to learn more about how treatment with LIBTAYO helped him when surgery and radiation were no longer options.